AnalystsMike MatsonMike Matson's Stock Forecasts
AnalystsMike Matson
Analyst Ranking
Bottom 1%
#4327 out of 4337 analysts
Average Return
-12.52%
Win Rate
30%73 out of 242
Risk vs Reward
Poor
Good
Mike Matson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cantel Medical CorpCMD | +158.06% | $31.93 | $82.40 | 2020-05-12 - 2021-01-13 | Buy |
Hologic IncHOLX | +102.55% | $34.06 | $68.99 | 2020-04-02 - 2020-11-20 | Buy |
Zimmer Biomet Holdings IncZBH | +59.70% | $101.91 | $162.75 | 2020-04-07 - 2021-04-07 | Strong Buy |
Penumbra IncPEN | +52.54% | $162.03 | $247.16 | 2022-11-04 - 2023-09-25 | Buy |
Masimo CorpMASI | +45.79% | $128.10 | $186.76 | 2022-05-04 - 2023-05-03 | Buy |
Mike Matson Analyst Color
Get additional color on Mike Matson's coverage of popular stocks
Mike Matson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Boston Scientific CorpBSX | 15 | Buy | $65.00 | +20.82% | Maintains | 6 days ago |
Resmed IncRMD | 4 | Buy | $180.00 | +30.16% | Upgrades | 21 days ago |
Lucid Diagnostics IncLUCD | 10 | Buy | $2.80 | +95.80% | Reiterates | a month ago |
Oncocyte CorpOCX | 9 | Buy | $4.25 | +32.81% | Maintains | 2 months ago |
Veracyte IncVCYT | 8 | Buy | $35.00 | +55.76% | Maintains | 2 months ago |
Personalis IncPSNL | 8 | Buy | $7.00 | +473.77% | Reiterates | 2 months ago |
Masimo CorpMASI | 11 | Buy | $136.00 | +48.85% | Reiterates | 2 months ago |
Neogenomics IncNEO | 13 | Buy | $21.00 | +69.90% | Reiterates | 2 months ago |
Shockwave Medical IncSWAV | 3 | Buy | $330.00 | +69.81% | Maintains | 2 months ago |
Artivion IncAORT | 11 | Buy | $26.00 | +70.94% | Reiterates | 2 months ago |
Enovis CorpENOV | 2 | Buy | $70.00 | +29.25% | Reiterates | 2 months ago |
Paragon 28 IncFNA | 7 | Buy | $24.00 | +83.07% | Reiterates | 2 months ago |
Surmodics IncSRDX | 10 | Buy | $50.00 | +55.62% | Reiterates | 2 months ago |
Orthopediatrics CorpKIDS | 9 | Buy | $55.00 | +67.02% | Reiterates | 2 months ago |
Hologic IncHOLX | 5 | Buy | $95.00 | +35.46% | Reiterates | 2 months ago |
Axonics IncAXNX | 14 | Buy | $76.00 | +37.18% | Maintains | 2 months ago |
Conmed CorpCNMD | 13 | Buy | $140.00 | +37.28% | Maintains | 2 months ago |
Livanova PLCLIVN | 12 | Buy | $71.00 | +31.34% | Reiterates | 2 months ago |
Atricure IncATRC | 15 | Buy | $68.00 | +63.07% | Maintains | 2 months ago |
Merit Medical Systems IncMMSI | 10 | Buy | $96.00 | +40.39% | Reiterates | 2 months ago |
Inogen IncINGN | 7 | Buy | $26.00 | +405.84% | Reiterates | 5 months ago |
Teleflex IncTFX | 4 | Buy | $291.00 | +43.04% | Reiterates | 7 months ago |
Penumbra IncPEN | 4 | Buy | $300.00 | +21.38% | Maintains | 7 months ago |
Inmode LtdINMD | 8 | Buy | $60.00 | +85.13% | Reiterates | 7 months ago |
Steris PLCSTE | 6 | Hold | N/A | N/A | Downgrades | a year ago |
Medtronic PLCMDT | 7 | Hold | N/A | N/A | Downgrades | a year ago |
Zimmer Biomet Holdings IncZBH | 15 | Hold | N/A | N/A | Downgrades | a year ago |
Cardiovascular Systems IncCSII | 4 | Hold | N/A | N/A | Downgrades | 2 years ago |
Invacare CorpIVCRQ | 1 | Buy | $8.00 | N/A | Maintains | 2 years ago |
Haemonetics CorpHAE | 5 | Buy | $108.00 | N/A | Maintains | 2 years ago |
Genmark Diagnostics IncGNMK | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Si Bone IncSIBN | 1 | Buy | $34.00 | N/A | Maintains | 3 years ago |
Globus Medical IncGMED | 1 | Buy | $75.00 | N/A | Maintains | 3 years ago |
Cantel Medical CorpCMD | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Hill Rom Holdings IncHRC | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Nuvasive IncNUVA | 1 | Buy | $74.00 | N/A | Upgrades | 3 years ago |
Wright Medical Group NvWMGI | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.